Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

ClinicalTrials.gov ID: NCT01312935

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01312935. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Proof of Concept Study of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study investigates the safety and efficacy of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Study identification

NCT ID: NCT01312935
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: PolyMedix, Inc.; Industry
Enrollment: 17 participants

Conditions and interventions

Conditions

Interventions

PMX-60056 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2011 (Type not available)
Primary completion: Jun 2012 (Estimated)
Completion: Aug 2012 (Estimated)
Last update posted: May 17, 2012

2011 – 2012

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Not listed	South Bend	Indiana	—	—
Not listed	Detroit	Michigan	—	—
Not listed	Rapid City	South Dakota	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01312935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 17, 2012 · Synced Nov 13, 2026